vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Virtu Financial, Inc. (VIRT). Click either name above to swap in a different company.
Virtu Financial, Inc. is the larger business by last-quarter revenue ($1.1B vs $950.5M, roughly 1.2× Astrana Health, Inc.). Virtu Financial, Inc. runs the higher net margin — 31.6% vs 0.7%, a 31.0% gap on every dollar of revenue. On growth, Virtu Financial, Inc. posted the faster year-over-year revenue change (389.3% vs 42.9%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 25.7%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
ASTH vs VIRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.1B |
| Net Profit | $6.6M | $346.6M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | — |
| Net Margin | 0.7% | 31.6% |
| Revenue YoY | 42.9% | 389.3% |
| Net Profit YoY | 184.4% | 82.8% |
| EPS (diluted) | $0.12 | $1.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.1B | ||
| Q4 25 | $950.5M | $969.9M | ||
| Q3 25 | $956.0M | $824.8M | ||
| Q2 25 | $654.8M | $999.6M | ||
| Q1 25 | $620.4M | $837.9M | ||
| Q4 24 | $665.2M | $834.3M | ||
| Q3 24 | $478.7M | $706.8M | ||
| Q2 24 | $486.3M | $693.0M |
| Q1 26 | — | $346.6M | ||
| Q4 25 | $6.6M | $139.9M | ||
| Q3 25 | $373.0K | $77.6M | ||
| Q2 25 | $9.4M | $151.2M | ||
| Q1 25 | $6.7M | $99.7M | ||
| Q4 24 | $-7.8M | $94.1M | ||
| Q3 24 | $16.1M | $60.0M | ||
| Q2 24 | $19.2M | $66.6M |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 35.4% | ||
| Q3 25 | 2.0% | 21.8% | ||
| Q2 25 | 3.1% | 34.7% | ||
| Q1 25 | 3.3% | 26.7% | ||
| Q4 24 | 0.1% | 24.3% | ||
| Q3 24 | 5.9% | 20.8% | ||
| Q2 24 | 6.2% | 22.4% |
| Q1 26 | — | 31.6% | ||
| Q4 25 | 0.7% | 14.4% | ||
| Q3 25 | 0.0% | 9.4% | ||
| Q2 25 | 1.4% | 15.1% | ||
| Q1 25 | 1.1% | 11.9% | ||
| Q4 24 | -1.2% | 11.3% | ||
| Q3 24 | 3.4% | 8.5% | ||
| Q2 24 | 3.9% | 9.6% |
| Q1 26 | — | $1.99 | ||
| Q4 25 | $0.12 | $1.54 | ||
| Q3 25 | $0.01 | $0.86 | ||
| Q2 25 | $0.19 | $1.65 | ||
| Q1 25 | $0.14 | $1.08 | ||
| Q4 24 | $-0.14 | $1.03 | ||
| Q3 24 | $0.33 | $0.64 | ||
| Q2 24 | $0.40 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $973.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $2.2B |
| Total Assets | $2.2B | $25.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $973.2M | ||
| Q4 25 | $429.5M | $1.1B | ||
| Q3 25 | $463.4M | $707.9M | ||
| Q2 25 | $342.1M | $752.1M | ||
| Q1 25 | $260.9M | $723.6M | ||
| Q4 24 | $290.8M | $872.5M | ||
| Q3 24 | $350.3M | $701.4M | ||
| Q2 24 | $327.7M | $684.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $779.3M | $1.6B | ||
| Q3 25 | $775.5M | $1.5B | ||
| Q2 25 | $765.5M | $1.4B | ||
| Q1 25 | $745.4M | $1.3B | ||
| Q4 24 | $712.7M | $1.3B | ||
| Q3 24 | $704.6M | $1.2B | ||
| Q2 24 | $678.9M | $1.2B |
| Q1 26 | — | $25.1B | ||
| Q4 25 | $2.2B | $20.2B | ||
| Q3 25 | $2.2B | $21.3B | ||
| Q2 25 | $1.4B | $19.3B | ||
| Q1 25 | $1.3B | $17.5B | ||
| Q4 24 | $1.4B | $15.4B | ||
| Q3 24 | $1.3B | $14.4B | ||
| Q2 24 | $1.3B | $13.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.29× | ||
| Q3 25 | — | 1.40× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | 1.39× | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 1.41× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $518.4M | ||
| Q3 25 | $10.0M | $-68.7M | ||
| Q2 25 | $90.9M | $62.8M | ||
| Q1 25 | $16.6M | $15.0M | ||
| Q4 24 | $-10.9M | $599.0M | ||
| Q3 24 | $34.0M | $112.1M | ||
| Q2 24 | $23.2M | $490.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $495.6M | ||
| Q3 25 | $7.4M | $-76.7M | ||
| Q2 25 | $89.5M | $57.6M | ||
| Q1 25 | $13.6M | $9.2M | ||
| Q4 24 | $-13.5M | $586.6M | ||
| Q3 24 | $31.7M | $106.2M | ||
| Q2 24 | $20.4M | $486.9M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 51.1% | ||
| Q3 25 | 0.8% | -9.3% | ||
| Q2 25 | 13.7% | 5.8% | ||
| Q1 25 | 2.2% | 1.1% | ||
| Q4 24 | -2.0% | 70.3% | ||
| Q3 24 | 6.6% | 15.0% | ||
| Q2 24 | 4.2% | 70.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 2.4% | ||
| Q3 25 | 0.3% | 1.0% | ||
| Q2 25 | 0.2% | 0.5% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 0.4% | 1.5% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.6% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 3.71× | ||
| Q3 25 | 26.69× | -0.89× | ||
| Q2 25 | 9.65× | 0.42× | ||
| Q1 25 | 2.48× | 0.15× | ||
| Q4 24 | — | 6.37× | ||
| Q3 24 | 2.11× | 1.87× | ||
| Q2 24 | 1.21× | 7.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
VIRT
| Trading income, net | $789.1M | 72% |
| Commissions, net and technology services | $186.6M | 17% |
| Other | $119.6M | 11% |
